CP and tuberculosis: First, we looked into the inflammatory marker proteins’ expression and found significantly higher circulatory ceruloplasmin and ferritin levels, and as expected, reduced abundance of these molecules was observed in ATB patients completing anti-TB therapy (Figures 6A, 7B) (16, 27, 28).